Skip to main content
Signal8

5AM Ventures V, L.P.

SEC insider (Form 3/4/5 filer). CIK 0001674324. 10% Owner at Entrada Therapeutics, Inc. (TRDA). 13 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in SAN FRANCISCO, CA.

Companies 5AM Ventures V, L.P. has filed insider reports for

  • Entrada Therapeutics, Inc. (TRDA): 10% Owner
5AM Ventures V, L.P. profile photo

5AM Ventures V, L.P.

CIK: 0001674324

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)13 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Entrada Therapeutics, Inc. logo
TRDA

Entrada Therapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (13 total)

  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Aug 7, 2026
    Sale
    Direct
    52.3K shares at avg. $6.85$358K
  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Aug 6, 2026
    Sale
    Direct
    10.5K shares at avg. $7.00$73K
  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Jul 31, 2026
    Sale
    Direct
    1.7K shares at avg. $6.85$12K
  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Jul 30, 2026
    Sale
    Direct
    114.8K shares at avg. $6.93$795K
  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Nov 14, 2025
    Sale
    Direct
    200K shares at avg. $8.80$1.8M
  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Jul 9, 2025
    Sale
    Direct
    20.1K shares at avg. $7.50$151K
  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Jul 9, 2025
    Sale
    Indirect
    6.9K shares at avg. $7.50$52K
  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Jul 1, 2025
    Sale
    Direct
    18.6K shares at avg. $7.12$132K
  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Jul 1, 2025
    Sale
    Indirect
    6.4K shares at avg. $7.12$46K
  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Jun 30, 2025
    Sale
    Direct
    18.6K shares at avg. $6.81$127K

1-10 of 13